The Trump administration in recent weeks has shifted its immigration enforcement rhetoric and tactics following the deaths of two U.S. citizens in Minnesota. Hundreds of Swiss bank accounts with ...

RXRX has reported updated data from its ELUCIDATE and TUPELO trials, but the stock has failed to mount a sustained rally. The ELUCIDATE update provides just an additional 10 patients of data treated ...

Add Yahoo as a preferred source to see more of our stories on Google. According to Daily Mail columnist Ephraim Hardcastle, King Charles III is "gently backtracking" and "regretting" Andrew ...

During a recent workshop, a senior executive said to me, “None of us knows how people will learn in this new era.” Lynda Gratton is a professor of management practice at London Business School and the ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

The Trump administration on Thursday said it would reduce the period of time that work permits are valid for refugees, asylees and other immigrants granted legal protections in the U.S., its latest ...

Billionaire Elon Musk is signaling that artificial intelligence and robotics could eliminate the need to work in the next few decades. Musk attended the U.S.-Saudi Investment Forum and was asked on a ...

From intern to editor, Damian Adams' story reads like a well-written novel where he steadily worked to become the youngest-ever editor of South Africa's leading motoring publication, CAR Magazine. He ...

Nvidia (NVDA) CEO Jensen Huang stated China is only nanoseconds behind the U.S. in AI development. China’s looser AI regulations and lower energy costs create a more conducive environment for rapid AI ...

I was never a coffee guy until I moved to Wisconsin and had a kid. Then, something about a piping hot caffeine-delivery service at a frigid 5 a.m. made a lot more sense. I'm still extremely basic with ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...